References

Anonymous, 1988. Headache classification committee of the international headache society classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia, 8: 1-96.
PubMed  |  

Brandes, J.L., 2002. Global trends in migraine care: Results from the MAZE survey. CNS Drugs, 16: 13-18.
PubMed  |  

Cananzi, A., R.G. D'Andrea, F. Perini, F. Zamberlan and K.M.A. Welch, 1995. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia, 15: 132-135.
CrossRef  |  

Chen, W.T., J.L. Fuh, S.R. Lu and S.J. Wang, 2001. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache, 41: 823-825.

Chronicle, E. and W. Mulleners, 2004. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst. Rev., 10.1002/14651858.CD003226.pub2

D'Andrea, G., F. Granella and F. Verdelli, 2002. Migraine with aura triggered by orgasm. Cephalalgia, 22: 485-486.
CrossRef  |  

D`Andrea, G., F. Granella, M. Cadaldini and G.C. Manzoni, 1999. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: An open pilot study. Cephalalgia, 19: 64-66.
CrossRef  |  

Ferrari, M.D., K. Odink, K.D. Bos, M.K.D. Malessy and G.W. Bruyn, 1990. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology, 40: 1582-1586.
PubMed  |  

Goadsby, P.J. and D.J. Classey, 2000. Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res., 875: 119-124.
PubMed  |  

Gorelova, N.A., V.I. Koroleva, T. Amemori, V. Pavlik and J. Bures, 1987. Ketamine blockade of cortical spreading depression in rats. Electroencephalogr. Clin. Neurophysiol., 66: 440-447.
PubMed  |  

Lampl, C., A. Buzarth, D. Klinger and K. Neumann, 1999. Lamotrigine in the prophylactic treatment of migraine aura: A pilot study. Cephalalgia, 19: 58-63.

Lauritzen, M., 1994. Pathophysiology of the migraine aura. The spreading depression theory. Brain, 117: 199-210.
PubMed  |  

Lees, G. and M.J. Leach, 1993. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res., 612: 190-199.
PubMed  |  

Limmroth, V., Z. Katsarava, G. Fritsche, S. Przywara and H.C. Diener, 2002. Features of medication overuse headache following overuse of different acute headache drugs. Neurology, 59: 1011-1014.
PubMed  |  

Lipton, R.B., S.W. Hamelsky, K.B. Kolodner, T.J. Steiner and W.F. Stewart, 2000. Migraine, quality of life and depression: A population-based case-control study. Neurology, 55: 629-635.
PubMed  |  

Maragakis, N.J. and J.D. Rothstein, 2001. Glutamate transporters in neurologic disease. Arch. Neurol., 58: 365-370.
PubMed  |  

Marrannes, R., R. Willems, E. De Prins and A. Wauquier, 1988. Evidence for a role of the N-methyl-D aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res., 457: 226-240.
PubMed  |  

Martinez, F., J. Castillo, J.R. Rodriguez, R. Leira and M. Noya, 1993. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia, 13: 89-93.
PubMed  |  

Pascual, J., A.B. Caminero, V. Mateos, C. Roig, R. Leira, C. Garcia-Monco and M.J. Lainez, 2004. Preventing disturbing migraine with aura with lamotrigine: An open pilot study. Headache, 44: 1024-1028.
PubMed  |  

Peres, M.F.P., E. Zukerman, C.A. Senne Soares, E.O. Alonso, B.F.C. Santos and M.H.W. Faulhaber, 2004. Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia, 24: 735-739.
CrossRef  |  Direct Link  |  

Schaumburg, H.H., R. Byck, R. Gerstl and J.H. Mashman, 1969. Monosodium L-glutamate: Its pharmacology and role in Chinese resturant syndrome. Science, 163: 826-828.
CrossRef  |  Direct Link  |  

Sherwin, A., Y. Robitaille, F. Quesney, A. Olivier and J. Villemure et al., 1988. Excitatory amino acids are elevated in human epileptic cerebral cortex. Neurology, 38: 920-923.
PubMed  |  

Silberstein, S.D., R.B. Lipton and P.J. Goadsby, 2002. Headache in Clinical Practice. 2nd Edn., Martin Dunitz, Oxford, England, pp: 287.

Terwindt, G.M., M.D. Ferrari, M. Tijhuis, S.M. Groenen, H.S. Picavet and L.J. Launer, 2000. The impact of migraine on quality of life in the general population: The GEM study. Neurology, 55: 624-629.
PubMed  |  

Tfelt-Hansen, P., G. Block, C. Dahlof, H.C. Diener and M.D. Ferrari et al., 2000. Guidelines for controlled trials of drugs in migraine. Cephalalagia, 20: 765-786.
PubMed  |  

Vaccaro, M., C. Riva, L. Tremolizzo, M. Longoni and A. Aliprandi et al., 2007. Platelet glutamate uptake and release in migraine with and without aura. Cephalalgia, 27: 35-40.
PubMed  |  

Vikelis, M. and A.M. Rapoport, 2010. Role of antiepileptic drugs as preventive agents for migraine. CNS Drugs, 24: 21-33.
PubMed  |  Direct Link  |  

Welch, K.M., G. D'Andrea, N. Tepley, G. Barkley and N.M. Ramadan, 1990. The concept of migraine as a state of central neuronal hyperexcitability. Neurol. Clin., 8: 817-828.
PubMed  |